
Mefsafe-D Tablet
Marketer
Biosafe Formulations
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Mefsafe-D Tablet
Abdominal discomfort is effectively addressed by the combined ingredients in D-Relief tablets. This medication alleviates pain, bloating, and cramping by relaxing gastrointestinal muscles and inhibiting pain-inducing neurotransmitters. Dosage and treatment duration for D-Relief should strictly follow your physician's instructions, tailored to your individual response and condition. Premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all concurrent medications, as interactions are possible. Common, usually transient, side effects include nausea, vomiting, diarrhea, stomach upset, dry mouth, decreased appetite, thirst, and heartburn. Report any concerning side effects immediately. Drowsiness and dizziness may occur; avoid driving or activities requiring alertness until the effects are known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Consult your physician before use if pregnant, planning pregnancy, breastfeeding, or with liver or kidney disease to ensure appropriate dosage.
Uses of Mefsafe-D Tablet
Managing abdominal discomfort
Major Benefits of Mefsafe-D Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mefsafe-D Tablets should be administered with a meal.
Common Side effects of Mefsafe-D Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Mefsafe-D Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Consume Mefsafe-D Tablet with a meal.
How Mefsafe-D Tablet works:
Combining drotaverine and mefenamic acid, Mefsafe-D tablets effectively alleviate abdominal discomfort and cramping. Drotaverine's antispasmodic action targets abdominal smooth muscle contractions, while mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the inflammatory chemical mediators responsible for pain and swelling in the abdomen.
SAFETY ADVICE
AlcoholUNSAFE
Combining Mefsafe-D Tablet and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Mefsafe-D tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Mefsafe-D Tablet with breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Mefsafe-D Tablet side effects, including potential vertigo.
KidneyCAUTION
Patients with kidney impairment should use Mefsafe-D Tablets cautiously, potentially requiring dosage modification under medical supervision. Mefsafe-D Tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Mefsafe-D Tablets judiciously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Mefsafe-D Tablet :
Should you forget a Mefsafe-D Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mefsafe-D Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
